Ready-to-use stabilized mRNA encoding Ovalbumin protein formulated in Lipid Nanoparticle.
LNP-mRNAs OVA have been designed to produce high expression level of Ovalbumin protein which is commonly used antigen for immunization and biochemical studies and an established model allergen for airway hyper-responsiveness. LNPs are suitable delivery systems for the parenteral administration routes.
Our delivery systems are produced through microfluidic technology resulting in monodisperse NanOZ LNP-mRNA with narrow size distribution and high encapsulation efficiency (>80%). We developed optimized LNP Immunization to improve stability and performance.
Concentration: 0.1 mg/mL mRNA in LNPs in PBS with 10% sucrose.
Kit content:
Quality Control:
| Items | Specification | Standard QC | Superior Grade QC* |
|---|---|---|---|
| Identity | Size | ✓ | ✓ |
| Charge | ✓ | ✓ | |
| Content | Encapsulation efficiency | ✓ | ✓ |
| RNA concentration | ✓ | ✓ | |
| Safety | Sterility | ✓ | ✓ |
| Endotoxin | ✓ | ||
| Mycoplasma detection | ✓ | ||
| Characterization | Lipid content | ✓ |
* our catalog LNP undergo the standard QC, Superior Grade QC can be performed as an additional prestation. Contact us to get a quote.
Storage: -80°C. We recommend to minimize freeze-thaw cycles to preserve LNPs integrity.
Shipping Conditions: Dry Ice. (Dry ice fee included in shipping cost.)
Please log in or register to see the prices for your country
| Catalog number | Unit Size | Price excl tax | Quantity / Buy |
| LNP10500MRNA41 |
0,5mL (2*250µL) of LNP-mRNA OVA
|
$750.00
|
|
| LNP11000MRNA41 |
1mL (4*250µL) of LNP-mRNA OVA
|
$1,319.00
|
|
| LNP15000MRNA41 |
5mL (20*250µL) of LNP-mRNA OVA
|
$5,063.00
|
|
| NAME | MOLECULE VECTOR | PRODUCT | REFERENCE | |
| all cells | 0 | NanOZ LNP Immunization | Iemitsu K. J Lipid Res. 2025 Dec 5:100956. | |
| all cells | 0 | NanOZ LNP Immunization | Jeger-Madiot R. J Exp Med. 2024 Oct 7;221(10):e20240289. |
Related products